SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001745020-23-000036
Filing Date
2023-06-13
Accepted
2023-06-13 17:29:18
Documents
1
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686691748.html 4  
1 FORM 4 wk-form4_1686691748.xml 4 7074
  Complete submission text file 0001745020-23-000036.txt   8432
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
GORDON CARL L (Reporting) CIK: 0001282930 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 231012278

Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations